In 2023, the use of peptic ulcer and gastro-oesophageal reflux diseases medicines in Italy was at 82.5 units (defined daily dosage) per thousand persons per day. The forecast from 2024 to 2028 indicates a gradual decline in consumption, dropping from 82.3 to 81.1 units. The year-on-year variation shows a slight annual decrease of approximately 0.4%, while the compound annual growth rate (CAGR) over this period signals a consistent diminishing trend.
Future trends to watch for include:
- Potential developments in treatment options that could influence medicine use.
- Changes in population demographics, possibly altering the demand dynamics.
- Health policy reforms that may impact prescription patterns and healthcare access.
